In The News

Eye on FDA


16 Nov 2021

Stacy Cline Amin spoke to POLITICO about former Food and Drug Administration (FDA) commissioner Robert Califf returning for a second tour atop the agency after a lengthy search by the Biden administration for a permanent leader.

According to Stacy, it will be interesting to see how Califf responds to questions about real-world evidence and clinical trial design during his confirmation hearing.

“It was one of his top priorities as commissioner, but I have seen some comments from him more recently looking critically at some of the use of real-world evidence and different forms of clinical trials during COVID-19,” Stacy said, citing a recent panel where Califf spoke.

Read the full article.



Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.